More on TPST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+85.5% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tempest Therapeutics (NQ:TPST)
Delayed: 0.97 -0.01 (1.02%)
Prev. Close $0.98  
Open$0.99 
52 Wk High$0.01 
52 Wk Low$0.00 
Day High$1.00 
Day Low$0.93 
P/E N/A  
EPS$0.00 
Volume206,287 

Friends, Peers and Foes (?): BDRX RXRX (more...)

Jul 17, 2026 04:32 PM Form DEF 14A Tempest Therapeutics, For: Jul 27
Jul 15, 2026 07:01 AM Tempest Therapeutics plans in vivo CAR-T trial for late 2026
Jul 15, 2026 07:00 AM Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
Jul 8, 2026 04:06 PM Form 424B3 Tempest Therapeutics,
Jul 8, 2026 06:03 AM Form EFFECT Tempest Therapeutics,
Jul 7, 2026 05:28 PM Form PRE 14A Tempest Therapeutics, For: Jul 27
Jun 26, 2026 04:05 PM Tempest Therapeutics (TPST) files for 2.43M share offering by selling stockholders
Jun 26, 2026 04:03 PM Form S-3 Tempest Therapeutics,
Jun 23, 2026 04:56 PM Form 4 Tempest Therapeutics, For: Mar 24 Filed by: Angel Matthew
Jun 23, 2026 06:04 AM Form 8-K Tempest Therapeutics, For: Jun 18
View All Articles

Entities mentioned with TPST

View All Entities